AOD 9604 is not FDA-approved and is sold as a research compound
(2012) Molecular Medicine , 18: 14301436 Randomised, double-blind pilot study confirming safety and efficacy of ARA-290 in sarcoidosis patients with small fibre neuropathy
In principle, by providing the special characteristics of the muscle-to-bone reattachment in rats after surgical detachment of the quadriceps muscle, these findings accord with and are supported by the healing effects so far reported on the recovery of muscles [30,31,32,33,34], tendons [27,28,29,34,35,36,37], ligaments [38], and bones [39,40,41], as well as injury and osteotendinous [27,28] and myotendinous [13] junction recovery
Available from: Krivic A, Anic T, Seiwerth S, Huljev D, Sikiric P
Step 3: Draw the Diluent Uncap your syringe